GSK plc - 10%+ Owner at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
LYEL on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by GSK plc since 06 Feb 2025

Holdings reported by GSK plc for Lyell Immunopharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 30,253,189 $68,977,271 $2.28 21 Jun 2021 Indirect
Series AA Preferred Stock 0 21 Jun 2021 Indirect Common Stock

Transactions reported by GSK plc for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.